Ultralife Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ultralife (ULBI).

Price Target Range — 3 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$14Upside to Avg. PT-10.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 15, 2024	Benchmark	Josh Sullivan	Maintained	Buy	$14
Jun 27, 2024	Benchmark	Josh Sullivan	PT Raise	Buy	$13→$14
Mar 5, 2024	Benchmark	Josh Sullivan	PT Raise	Buy	$12→$13

Analyst Ratings News

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.

Rishabh Mishra

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $14 price target.

Benzinga Newsdesk

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14

Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $13 to $14.

Benzinga Newsdesk

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $13

Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $12 to $13.

Benzinga Newsdesk

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $12 price target.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021

Benzinga Insights

Ultralife Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Ultralife Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $13

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021

People Also Watch

People Also Watch

Ultralife Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Ultralife Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

PROBenchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

PROBenchmark Maintains Buy on Ultralife, Raises Price Target to $14

PROBenchmark Maintains Buy on Ultralife, Raises Price Target to $13

PROBenchmark Reiterates Buy on Ultralife, Maintains $12 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021

People Also Watch

People Also Watch

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $13

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target